Insys Agrees to Pay $150 Million to Settle Opioid Sales Probe
This article is for subscribers only.
Pharmaceutical company Insys Therapeutics Inc. said it reached a $150 million settlement with the U.S. Department of Justice to resolve a civil and criminal probe into inappropriate sales of opioid-based painkillers by former employees.
The settlement will be paid over five years and could increase by as much as $75 million in contingency-based payments if certain unspecified events occur before the deal is finalized, the Chandler, Arizona-based company said Wednesday in a statement.